60 Degrees Pharma reached minimum enrollment for interim analysis of its hospitalized babesiosis trial, with data expected by October 6, 2026....
60 Degrees Pharma reached minimum enrollment for interim analysis of its hospitalized babesiosis trial, with data expected by October 6, 2026....